Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.

PloS one

Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S.
PMID: 26114293
PLoS One. 2015 Jun 26;10(6):e0130917. doi: 10.1371/journal.pone.0130917. eCollection 2015.

No abstract available.

Cite
Sripan P, Le Coeur S, Amzal B, et al. Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015;10(6):e0130917doi: 10.1371/journal.pone.0130917.
Sripan, P., Le Coeur, S., Amzal, B., Ingsrisawang, L., Traisathit, P., Ngo-Giang-Huong, N., McIntosh, K., Cressey, T. R., Sangsawang, S., Rawangban, B., Kanjanavikai, P., Tréluyer, J. M., Jourdain, G., Lallemant, M., & Urien, S. (2015). Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PloS one, 10(6), e0130917. https://doi.org/10.1371/journal.pone.0130917
Sripan, Patumrat, et al. "Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV." PloS one vol. 10,6 (2015): e0130917. doi: https://doi.org/10.1371/journal.pone.0130917
Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015 Jun 26;10(6):e0130917. doi: 10.1371/journal.pone.0130917. eCollection 2015. PMID: 26114293; PMCID: PMC4482690.
Copy Download .nbib Format: NLM
Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV.

Journal of clinical medicine

Dub T, Le Cœur S, Ngo-Giang-Huong N, Matanasarawut W, Suriyachai P, Saisawat K, Putiyanun C, Buranabanjasatean S, Leenasirimakul P, Randaeng S, Delory T.
PMID: 34300302
J Clin Med. 2021 Jul 15;10(14). doi: 10.3390/jcm10143133.

Even when receiving combination antiretroviral therapy, women living with HIV are at high risk of human papillomavirus (HPV) infection and/or cervical lesions, including cancer. Using data from the PapilloV prospective cohort, we evaluated the prevalence of high-risk HPV (HR-HPV)...

Cite
Dub T, Le Cœur S, Ngo-Giang-Huong N, et al. Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV. J Clin Med. 2021;10(14)doi: 10.3390/jcm10143133.
Dub, T., Le Cœur, S., Ngo-Giang-Huong, N., Matanasarawut, W., Suriyachai, P., Saisawat, K., Putiyanun, C., Buranabanjasatean, S., Leenasirimakul, P., Randaeng, S., & Delory, T. (2021). Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV. Journal of clinical medicine, 10(14), . https://doi.org/10.3390/jcm10143133
Dub, Timothée, et al. "Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV." Journal of clinical medicine vol. 10,14 (2021). doi: https://doi.org/10.3390/jcm10143133
Dub T, Le Cœur S, Ngo-Giang-Huong N, Matanasarawut W, Suriyachai P, Saisawat K, Putiyanun C, Buranabanjasatean S, Leenasirimakul P, Randaeng S, Delory T. Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV. J Clin Med. 2021 Jul 15;10(14). doi: 10.3390/jcm10143133. PMID: 34300302; PMCID: PMC8305309.
Copy Download .nbib Format: NLM
Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.

Expert opinion on medical diagnostics

Rouet F, Liégeois F, Mouinga-Ondémé A, Kania D, Viljoen J, Wambua S, Ngo-Giang-Huong N, Ménan H, Peeters M, Nerrienet E.
PMID: 23484497
Expert Opin Med Diagn. 2011 May;5(3):183-202. doi: 10.1517/17530059.2011.566860. Epub 2011 Mar 29.

INTRODUCTION: One of the major characteristics of HIV-1 is its extreme genetic diversity. A key factor in assessing the sensitivity of a molecular-based assay measuring HIV-1 RNA viral load (VL) in plasma is its ability to detect/quantify all (or...

Cite
Rouet F, Liégeois F, Mouinga-Ondémé A, et al. Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert Opin Med Diagn. 2011;5(3):183-202doi: 10.1517/17530059.2011.566860.
Rouet, F., Liégeois, F., Mouinga-Ondémé, A., Kania, D., Viljoen, J., Wambua, S., Ngo-Giang-Huong, N., Ménan, H., Peeters, M., & Nerrienet, E. (2011). Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert opinion on medical diagnostics, 5(3), 183-202. https://doi.org/10.1517/17530059.2011.566860
Rouet, François, et al. "Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1." Expert opinion on medical diagnostics vol. 5,3 (2011): 183-202. doi: https://doi.org/10.1517/17530059.2011.566860
Rouet F, Liégeois F, Mouinga-Ondémé A, Kania D, Viljoen J, Wambua S, Ngo-Giang-Huong N, Ménan H, Peeters M, Nerrienet E. Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. Expert Opin Med Diagn. 2011 May;5(3):183-202. doi: 10.1517/17530059.2011.566860. Epub 2011 Mar 29. PMID: 23484497.
Copy Download .nbib Format: NLM
Association between lymphocyte and monocyte subsets and cognition in children with HIV.

AIDS research and therapy

Ananworanich J, Bunupuradah T, Apornpong T, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Ngo-Giang-Huong N, Jaimulwong T, Kerr SJ, Brouwers P, Shearer WT, Puthanakit T.
PMID: 24450991
AIDS Res Ther. 2014 Jan 22;11(1):7. doi: 10.1186/1742-6405-11-7.

BACKGROUND: This study assesses the relationships between lymphocyte and monocyte subsets and intelligence quotient (IQ) scores in antiretroviral therapy (ART)-naive, HIV-infected Thai children without advanced HIV disease.FINDINGS: Sixty-seven ART-naive Thai children with CD4 between 15-24% underwent cognitive testing by...

Cite
Ananworanich J, Bunupuradah T, Apornpong T, et al. Association between lymphocyte and monocyte subsets and cognition in children with HIV. AIDS Res Ther. 2014;11(1):7doi: 10.1186/1742-6405-11-7.
Ananworanich, J., Bunupuradah, T., Apornpong, T., Kosalaraksa, P., Hansudewechakul, R., Kanjanavanit, S., Ngampiyaskul, C., Wongsawat, J., Luesomboon, W., Ngo-Giang-Huong, N., Jaimulwong, T., Kerr, S. J., Brouwers, P., Shearer, W. T., Puthanakit, T. (2014). Association between lymphocyte and monocyte subsets and cognition in children with HIV. AIDS research and therapy, 11(1), 7. https://doi.org/10.1186/1742-6405-11-7
Ananworanich, Jintanat, et al. "Association between lymphocyte and monocyte subsets and cognition in children with HIV." AIDS research and therapy vol. 11,1 (2014): 7. doi: https://doi.org/10.1186/1742-6405-11-7
Ananworanich J, Bunupuradah T, Apornpong T, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Ngo-Giang-Huong N, Jaimulwong T, Kerr SJ, Brouwers P, Shearer WT, Puthanakit T. Association between lymphocyte and monocyte subsets and cognition in children with HIV. AIDS Res Ther. 2014 Jan 22;11(1):7. doi: 10.1186/1742-6405-11-7. PMID: 24450991; PMCID: PMC3900937.
Copy Download .nbib Format: NLM
Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo.

Journal of tropical medicine

Lallemant C, Halembokaka G, Baty G, Ngo-Giang-Huong N, Barin F, Le Coeur S.
PMID: 20847934
J Trop Med. 2010;2010. doi: 10.1155/2010/897176. Epub 2010 Aug 17.

Few studies have documented the contribution of HIV/AIDS to mortality among children under 15 years. From June 30 to October 19, 2001, all child deaths (n = 588) registered to the morgue and/or hospitals of the city of Pointe-Noire,...

Cite
Lallemant C, Halembokaka G, Baty G, et al. Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo. J Trop Med. 2010;2010doi: 10.1155/2010/897176.
Lallemant, C., Halembokaka, G., Baty, G., Ngo-Giang-Huong, N., Barin, F., & Le Coeur, S. (2010). Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo. Journal of tropical medicine, 2010. https://doi.org/10.1155/2010/897176
Lallemant, Camille, et al. "Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo." Journal of tropical medicine vol. 2010 (2010). doi: https://doi.org/10.1155/2010/897176
Lallemant C, Halembokaka G, Baty G, Ngo-Giang-Huong N, Barin F, Le Coeur S. Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo. J Trop Med. 2010;2010. doi: 10.1155/2010/897176. Epub 2010 Aug 17. PMID: 20847934; PMCID: PMC2933897.
Copy Download .nbib Format: NLM
Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015.

Viruses

Ngo-Giang-Huong N, Leroi C, Fusco D, Cressey TR, Wangsaeng N, Salvadori N, Kongyai N, Sirirungsi W, Lallemant M, Auewarakul P, Khamduang W, Jourdain G.
PMID: 34452289
Viruses. 2021 Jul 22;13(8). doi: 10.3390/v13081423.

Data about Zika virus infection and adverse pregnancy outcomes in Southeast Asia are scarce. We conducted an unmatched case-control study of Zika virus (ZIKV) serology in pregnant women enrolled in human immunodeficiency virus (HIV) or hepatitis B virus (HBV)...

Cite
Ngo-Giang-Huong N, Leroi C, Fusco D, et al. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses. 2021;13(8)doi: 10.3390/v13081423.
Ngo-Giang-Huong, N., Leroi, C., Fusco, D., Cressey, T. R., Wangsaeng, N., Salvadori, N., Kongyai, N., Sirirungsi, W., Lallemant, M., Auewarakul, P., Khamduang, W., & Jourdain, G. (2021). Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses, 13(8), . https://doi.org/10.3390/v13081423
Ngo-Giang-Huong, Nicole, et al. "Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015." Viruses vol. 13,8 (2021). doi: https://doi.org/10.3390/v13081423
Ngo-Giang-Huong N, Leroi C, Fusco D, Cressey TR, Wangsaeng N, Salvadori N, Kongyai N, Sirirungsi W, Lallemant M, Auewarakul P, Khamduang W, Jourdain G. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses. 2021 Jul 22;13(8). doi: 10.3390/v13081423. PMID: 34452289; PMCID: PMC8402824.
Copy Download .nbib Format: NLM
Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.

PloS one

Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S.
PMID: 26317220
PLoS One. 2015 Aug 28;10(8):e0137368. doi: 10.1371/journal.pone.0137368. eCollection 2015.

No abstract available.

Cite
Sripan P, Le Coeur S, Amzal B, et al. Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015;10(8):e0137368doi: 10.1371/journal.pone.0137368.
Sripan, P., Le Coeur, S., Amzal, B., Ingsrisawang, L., Traisathit, P., Ngo-Giang-Huong, N., McIntosh, K., Cressey, T. R., Sangsawang, S., Rawangban, B., Kanjanavikai, P., Tréluyer, J. M., Jourdain, G., Lallemant, M., & Urien, S. (2015). Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PloS one, 10(8), e0137368. https://doi.org/10.1371/journal.pone.0137368
Sripan, Patumrat, et al. "Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV." PloS one vol. 10,8 (2015): e0137368. doi: https://doi.org/10.1371/journal.pone.0137368
Sripan P, Le Coeur S, Amzal B, Ingsrisawang L, Traisathit P, Ngo-Giang-Huong N, McIntosh K, Cressey TR, Sangsawang S, Rawangban B, Kanjanavikai P, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One. 2015 Aug 28;10(8):e0137368. doi: 10.1371/journal.pone.0137368. eCollection 2015. PMID: 26317220; PMCID: PMC4552690.
Copy Download .nbib Format: NLM
HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination.

EClinicalMedicine

Ngo-Giang-Huong N, Aghokeng AF.
PMID: 31143873
EClinicalMedicine. 2019 Apr 01;9:3-4. doi: 10.1016/j.eclinm.2019.03.013. eCollection 2019 Mar.

No abstract available.

Cite
Ngo-Giang-Huong N, Aghokeng AF. HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination. EClinicalMedicine. 2019;9:3-4doi: 10.1016/j.eclinm.2019.03.013.
Ngo-Giang-Huong, N., & Aghokeng, A. F. (2019). HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination. EClinicalMedicine, 93-4. https://doi.org/10.1016/j.eclinm.2019.03.013
Ngo-Giang-Huong, Nicole, and Aghokeng, Avelin F. "HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination." EClinicalMedicine vol. 9 (2019): 3-4. doi: https://doi.org/10.1016/j.eclinm.2019.03.013
Ngo-Giang-Huong N, Aghokeng AF. HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination. EClinicalMedicine. 2019 Apr 01;9:3-4. doi: 10.1016/j.eclinm.2019.03.013. eCollection 2019 Mar. PMID: 31143873; PMCID: PMC6510715.
Copy Download .nbib Format: NLM
Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015.

Viruses

Ngo-Giang-Huong N, Leroi C, Fusco D, Cressey TR, Wangsaeng N, Salvadori N, Kongyai N, Sirirungsi W, Lallemant M, Auewarakul P, Khamduang W, Jourdain G.
PMID: 34452289
Viruses. 2021 Jul 22;13(8). doi: 10.3390/v13081423.

Data about Zika virus infection and adverse pregnancy outcomes in Southeast Asia are scarce. We conducted an unmatched case-control study of Zika virus (ZIKV) serology in pregnant women enrolled in human immunodeficiency virus (HIV) or hepatitis B virus (HBV)...

Cite
Ngo-Giang-Huong N, Leroi C, Fusco D, et al. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses. 2021;13(8)doi: 10.3390/v13081423.
Ngo-Giang-Huong, N., Leroi, C., Fusco, D., Cressey, T. R., Wangsaeng, N., Salvadori, N., Kongyai, N., Sirirungsi, W., Lallemant, M., Auewarakul, P., Khamduang, W., & Jourdain, G. (2021). Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses, 13(8), . https://doi.org/10.3390/v13081423
Ngo-Giang-Huong, Nicole, et al. "Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015." Viruses vol. 13,8 (2021). doi: https://doi.org/10.3390/v13081423
Ngo-Giang-Huong N, Leroi C, Fusco D, Cressey TR, Wangsaeng N, Salvadori N, Kongyai N, Sirirungsi W, Lallemant M, Auewarakul P, Khamduang W, Jourdain G. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses. 2021 Jul 22;13(8). doi: 10.3390/v13081423. PMID: 34452289; PMCID: PMC8402824.
Copy Download .nbib Format: NLM
Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications.

Infection and drug resistance

Jourdain G, Ngo-Giang-Huong N, Khamduang W.
PMID: 31118703
Infect Drug Resist. 2019 Apr 26;12:977-987. doi: 10.2147/IDR.S171695. eCollection 2019.

There is currently no cure for hepatitis B chronic infections. Because new hepatitis B infections result mainly from perinatal transmission, preventing mother-to-child transmission is essential to reach by 2030 the goal of hepatitis B elimination set by the World...

Cite
Jourdain G, Ngo-Giang-Huong N, Khamduang W. Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications. Infect Drug Resist. 2019;12:977-987doi: 10.2147/IDR.S171695.
Jourdain, G., Ngo-Giang-Huong, N., & Khamduang, W. (2019). Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications. Infection and drug resistance, 12977-987. https://doi.org/10.2147/IDR.S171695
Jourdain, Gonzague, et al. "Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications." Infection and drug resistance vol. 12 (2019): 977-987. doi: https://doi.org/10.2147/IDR.S171695
Jourdain G, Ngo-Giang-Huong N, Khamduang W. Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications. Infect Drug Resist. 2019 Apr 26;12:977-987. doi: 10.2147/IDR.S171695. eCollection 2019. PMID: 31118703; PMCID: PMC6499137.
Copy Download .nbib Format: NLM
Uncommon hepatitis C virus among migrant sex workers in Chiangmai, Thailand.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Hongjaisee S, Khamduang W, Sripan P, Choyrum S, Thepbundit V, Kosashunhanan N, Ngo-Giang-Huong N, Tangmunkongvorakul A.
PMID: 34015529
Clin Microbiol Infect. 2021 Oct;27(10):1523-1525. doi: 10.1016/j.cmi.2021.05.013. Epub 2021 May 17.

No abstract available.

Cite
Hongjaisee S, Khamduang W, Sripan P, et al. Uncommon hepatitis C virus among migrant sex workers in Chiangmai, Thailand. Clin Microbiol Infect. 2021;27(10):1523-1525doi: 10.1016/j.cmi.2021.05.013.
Hongjaisee, S., Khamduang, W., Sripan, P., Choyrum, S., Thepbundit, V., Kosashunhanan, N., Ngo-Giang-Huong, N., & Tangmunkongvorakul, A. (2021). Uncommon hepatitis C virus among migrant sex workers in Chiangmai, Thailand. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(10), 1523-1525. https://doi.org/10.1016/j.cmi.2021.05.013
Hongjaisee, Sayamon, et al. "Uncommon hepatitis C virus among migrant sex workers in Chiangmai, Thailand." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 27,10 (2021): 1523-1525. doi: https://doi.org/10.1016/j.cmi.2021.05.013
Hongjaisee S, Khamduang W, Sripan P, Choyrum S, Thepbundit V, Kosashunhanan N, Ngo-Giang-Huong N, Tangmunkongvorakul A. Uncommon hepatitis C virus among migrant sex workers in Chiangmai, Thailand. Clin Microbiol Infect. 2021 Oct;27(10):1523-1525. doi: 10.1016/j.cmi.2021.05.013. Epub 2021 May 17. PMID: 34015529.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries